1. Home
  2. APGE vs PRKS Comparison

APGE vs PRKS Comparison

Compare APGE & PRKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APGE
  • PRKS
  • Stock Information
  • Founded
  • APGE 2022
  • PRKS 1959
  • Country
  • APGE United States
  • PRKS United States
  • Employees
  • APGE N/A
  • PRKS N/A
  • Industry
  • APGE Biotechnology: Biological Products (No Diagnostic Substances)
  • PRKS Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • APGE Health Care
  • PRKS Health Care
  • Exchange
  • APGE Nasdaq
  • PRKS Nasdaq
  • Market Cap
  • APGE 2.1B
  • PRKS 2.4B
  • IPO Year
  • APGE 2023
  • PRKS 2013
  • Fundamental
  • Price
  • APGE $44.32
  • PRKS $49.39
  • Analyst Decision
  • APGE Strong Buy
  • PRKS Buy
  • Analyst Count
  • APGE 4
  • PRKS 13
  • Target Price
  • APGE $97.50
  • PRKS $57.85
  • AVG Volume (30 Days)
  • APGE 913.3K
  • PRKS 698.9K
  • Earning Date
  • APGE 08-11-2025
  • PRKS 08-06-2025
  • Dividend Yield
  • APGE N/A
  • PRKS N/A
  • EPS Growth
  • APGE N/A
  • PRKS 3.53
  • EPS
  • APGE N/A
  • PRKS 3.85
  • Revenue
  • APGE N/A
  • PRKS $1,714,827,000.00
  • Revenue This Year
  • APGE N/A
  • PRKS $2.47
  • Revenue Next Year
  • APGE $743.14
  • PRKS $2.32
  • P/E Ratio
  • APGE N/A
  • PRKS $12.84
  • Revenue Growth
  • APGE N/A
  • PRKS N/A
  • 52 Week Low
  • APGE $26.20
  • PRKS $37.68
  • 52 Week High
  • APGE $63.50
  • PRKS $60.83
  • Technical
  • Relative Strength Index (RSI)
  • APGE 61.88
  • PRKS 70.44
  • Support Level
  • APGE $42.88
  • PRKS $44.61
  • Resistance Level
  • APGE $44.61
  • PRKS $49.97
  • Average True Range (ATR)
  • APGE 2.37
  • PRKS 1.46
  • MACD
  • APGE 0.12
  • PRKS 0.76
  • Stochastic Oscillator
  • APGE 63.45
  • PRKS 93.78

About APGE Apogee Therapeutics Inc.

Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

About PRKS United Parks & Resorts Inc. Common Stock

United Parks & Resorts Inc is an American theme park and entertainment company. Its core business is the operation of theme parks and entertainment facilities involving sea animals across the country under prominent brands such as SeaWorld, Busch Gardens, Aquatica, Discovery Cove, and Sesame Place. The company generates the majority of its revenue from selling admission tickets for its theme parks.

Share on Social Networks: